(R)-1-(4-Bromo-2-fluorophenyl)ethanamine hydrochloride
97%
- Product Code: 113463
CAS:
845829-91-6
| Molecular Weight: | 254.53 g./mol | Molecular Formula: | C₈H₁₀BrClFN |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD19105430 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, dry and sealed |
Product Description:
This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its chiral nature makes it particularly valuable in the production of enantiomerically pure drugs, which often exhibit improved efficacy and reduced side effects compared to their racemic counterparts. The presence of the bromo and fluoro substituents on the aromatic ring enhances its reactivity, allowing for further functionalization in complex organic syntheses. It is commonly employed in the development of central nervous system (CNS) drugs, including those targeting neurological disorders such as depression, anxiety, and schizophrenia. Additionally, its structural features make it a useful building block in medicinal chemistry for designing molecules with specific biological activities.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $353.36 |
+
-
|
| 0.250 | 10-20 days | $530.46 |
+
-
|
| 1.000 | 10-20 days | $1,325.51 |
+
-
|
(R)-1-(4-Bromo-2-fluorophenyl)ethanamine hydrochloride
This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its chiral nature makes it particularly valuable in the production of enantiomerically pure drugs, which often exhibit improved efficacy and reduced side effects compared to their racemic counterparts. The presence of the bromo and fluoro substituents on the aromatic ring enhances its reactivity, allowing for further functionalization in complex organic syntheses. It is commonly employed in the development of central nervous system (CNS) drugs, including those targeting neurological disorders such as depression, anxiety, and schizophrenia. Additionally, its structural features make it a useful building block in medicinal chemistry for designing molecules with specific biological activities.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :